Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Francois Baclesse
Age
50–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 50 years and ≤ 75 years
Life expectancy \>10 years
Localized prostatic adenocarcinoma and histologically proven
Intermediate risk cancer(T2b or PSA between 10 and 20 or Gleason = 7(3+4) according to Amico criteria
Metastasis or pelvic pathologic ganglion (≥ 10 mm) absence
OMS \< 2
No previous treatment by radiotherapy and/or curietherapy
Hormonotherapy authorized before and during the study
Rectal or uretero-vesical pathology
Signed informed consent
Social security system affiliation
Individual deprived of liberty or placed under the authority of a tutor.
No anesthesia contraindication
You may not be if
Adenocarcinoma not histologically proven
Metastases presence
Pathological nodes presence(≥ 10 mm)
Prior prostate endoscopic resection
history of other malignancy except for appropriately treated superficial basal cell skin cancer
Medical contraindications to anesthesia
Patients with uncontrolled psychiatric disease or medical disease incompatible with the protocol
Impossibility to respect the medical follow-up of the protocol for geographical, social or psychic reasons
Clareo Health | Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer
